Viewing Study NCT06325332


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-05 @ 6:09 PM
Study NCT ID: NCT06325332
Status: COMPLETED
Last Update Posted: 2025-11-05
First Post: 2024-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module